Literature DB >> 26262452

Inflammatory Myofibroblastic Tumor of the Placenta: A Report of a Novel Lesion in 2 Patients.

Natalie Banet1, Yi Ning, Elizabeth A Montgomery.   

Abstract

Inflammatory myofibroblastic tumor has been described in a wide variety of anatomic sites, although in the gynecologic tract, it has mostly been documented in the uterus, and has never been described in the placenta. Two patients presented with well-circumscribed placental masses that showed classic histologic features of inflammatory myofibroblastic tumor including a proliferation of myofibroblastic cells, a mixed inflammatory infiltrate, and a myxoid background. One case was positive by immunohistochemistry for anaplastic lymphoma kinase (ALK-1), whereas the other was negative by immunohistochemistry and fluorescent in situ hybridization. Inflammatory myofibroblastic tumors should be differentiated from other more aggressive uterine tumors that may involve the placenta by direct extension/metastasis because they can be managed conservatively, and in these 2 cases, did not seem to affect the course of the patient's pregnancies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26262452     DOI: 10.1097/PGP.0000000000000175

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  2 in total

1.  Inflammatory myofibroblastic tumor of the uterus: a clinicopathological, immunohistochemical, and molecular analysis of 13 cases highlighting their broad morphologic spectrum.

Authors:  Jennifer A Bennett; Valentina Nardi; Marjan Rouzbahman; Vicente Morales-Oyarvide; G Petur Nielsen; Esther Oliva
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

2.  Inflammatory Myofibroblastic Tumor of the Breast Coexisting with Pseudoangiomatous Stromal Hyperplasia.

Authors:  Canan Kelten Talu; Yasemin Çakır; Ezgi Hacıhasanoğlu; Cem Leblebici; Şefika Aksoy; Mehmet Ali Nazlı
Journal:  J Breast Health       Date:  2016-10-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.